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ABSTRACT
The ability to generate RNA aptamers for synthetic
biology using in vitro selection depends on the
informational complexity (IC) needed to specify
functional structures that bind target ligands with
desired affinities in physiological concentrations of
magnesium. We investigate how selection for
high-affinity aptamers is constrained by chemical
properties of the ligand and the need to bind in
low magnesium. We select two sets of RNA
aptamers that bind planar ligands with dissociation
constants (Kds) ranging from 65nM to 100 kM in
physiological buffer conditions. Aptamers selected
to bind the non-proteinogenic amino acid, p-amino
phenylalanine (pAF), are larger and more informa-
tionally complex (i.e., rarer in a pool of random
sequences) than aptamers selected to bind a
larger fluorescent dye, tetramethylrhodamine
(TMR). Interestingly, tighter binding aptamers show
less dependence on magnesium than weaker-
binding aptamers. Thus, selection for high-affinity
binding may automatically lead to structures that
are functional in physiological conditions
(1–2.5mM Mg2+). We hypothesize that selection for
high-affinity binding in physiological conditions is
primarily constrained by ligand characteristics
such as molecular weight (MW) and the number of
rotatable bonds. We suggest that it may be possible
to estimate aptamer–ligand affinities and predict
whether a particular aptamer-based design goal is
achievable before performing the selection.
INTRODUCTION
RNA structures have emerged as important tools for pro-
gramming gene expression for metabolic engineering and
synthetic biology (1–5). Dynamic genetic controls respon-
sive to small molecule ligands can be constructed from
RNA aptamers generated with in vitro selection (6–8). In
principle, aptamer-based genetic controls could be used as
in situ readouts of product formation or as feedback
mechanisms for regulating metabolic flux through engi-
neered pathways in response to any desired metabolite (9).
Several different mechanistic approaches have been
devised to couple fluctuations in the concentration of a
metabolite to changes in gene expression using RNA
aptamers. For example, a synthetic riboswitch that
anti-attenuates translation in Bacillus subtilis was made
by incorporating an in vitro selected aptamer that binds
theophylline (10) into the region just upstream of the
Shine–Dalgarno (SD) sequence of a reporter gene
(11,12). Adding ligand to the cell activates translation
more than 3-fold because ligand-binding stabilizes an
aptamer conformation that reduces the amount of second-
ary structure involving the SD sequence. A screen for syn-
thetic gene-regulatory aptamers identified theophylline
aptamer structures that employ a similar mechanism to
activate translation up to 35-fold upon the addition of
ligand (13). Gene expression has also been modulated by
controlling mRNA stability and access to the ribosome
binding site using synthetic aptamer-controlled self-
cleaving RNA structures (‘aptazymes’) (14–18).
Regardless of the specific genetic control mechanism
to be employed, it is impractical to generate or select
high-affinity aptamers directly in vivo. This is because
the frequency of functional ligand-binding structures in
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RNA sequence space is small (from 1 in 109 for
low-affinity aptamers to 1 in 1020 for very high-affinity
aptamers (19)) compared to the size of the sequence
library that can be directly searched due to the limit
imposed by transformation efficiency, 109 in an
organism such as Escherichia coli (20). However, in vitro
affinity chromatography selections can be used to search
libraries containing >1015 unique molecules, providing
access to aptamers that bind target ligands with very
high affinity.
To date, a large number of the examples
(12,17,18,21,22) of synthetic aptamer-based control of
living systems have used the theophylline aptamer, first
selected by Jenison et al. (10) almost 15 years ago.
Although that selection was not intended to produce
structures for use in vivo, the theophylline aptamer has
been repeatedly employed because it is small (15 nt
binding site), discriminates between two closely related
cell-permeable molecules (theophylline and caffeine), and
binds with high affinity in physiological concentrations of
magnesium (the aptamer–ligand dissociation constant (kd)
is 400 nM in 1mM Mg2+). The latter point is significant
because RNA function tends to decrease at lower concen-
trations of magnesium (5), such as those typically found
intracellularly (0.5mM to 1.5mM (23)). Since the RNA
backbone is polyanionic, the negative–negative charge
repulsion may inhibit formation of complex structures in
the absence of counterions. Divalent cations like Mg2+
can help screen this charge and enable the backbone to
fold closer to itself (24).
Many selections, generally carried out in 5–10mM
Mg2+, have isolated aptamers that bind targets such as
amino acids, proteins and nucleotides (8). While some of
the resulting structures may bind in physiological condi-
tions (25–28), we are interested in knowing whether
lowering the magnesium concentration increases the
informational complexities (ICs) (i.e. lowers the probabil-
ity of finding a functional molecule in sequence space) of
functional aptamers such that the probability of selecting
active molecules becomes very low (19).
Here we investigated both how the need to bind in phys-
iological magnesium concentrations affect selection and
aptamer affinity and how ligand MW and chemical char-
acteristics affect potential aptamer affinity. We addressed
these questions by in vitro selecting aptamers that bind
two different cell-permeable small molecules, p-amino-
phenylalanine (pAF) and tetramethylrhodamine (TMR),
(Figure 1). pAF is an non-proteinogenic amino acid
(MW=162 g/mol) that can be produced heterologously
in vivo in E. coli from Streptomyces venezualea gene
products and is a precursor for making the pristanamycin
family of antibiotics (29). With a small, relatively simple
structure, it is representative of other metabolic building
blocks; it has four potential hydrogen bond-forming
moieties and a single aromatic ring. TMR is a larger
fluorogenic molecule (MW=343 g/mol) with four
aromatic rings. TMR is presumably an easier binding
target for RNA than pAF and is representative of more
complicated polycyclic organic compounds that might be
found in the later stages of an engineered biosynthetic
pathway (Figure 1).
We conducted parallel selections for pAF aptamers with
four different concentrations of magnesium (1, 2.5, 5 and
10mM). After 10 rounds, all of the selections produced
molecules that bound pAF, though there were fewer dif-
ferent sequences in the 1 and 2.5mM Mg2+ selections
than the 5 and 10mM selections. Two of the pAF struc-
tures were isolated and reselected to generate IC and
affinity profiles. We selected four different TMR
aptamers in 1mM Mg2+ and characterized them in the
same way. We then compared the IC and binding affinities
of these newly selected aptamers to structures in the liter-
ature. We found that aptamers selected in physiological
concentrations of magnesium have ICs consistent with
those selected in more permissive conditions and show
that aptamer IC versus ligand affinity relationships can,
to a first approximation, be grouped according to ligand
molecular weight (MW). Our results suggest that it may be
possible to predict aptamer affinities for a target ligand
on the basis of MW and chemical properties before per-
forming the selection. We discuss the implications of these
findings for the application of in vitro selected RNA
aptamers as genetic controls for synthetic biological
systems.
MATERIALS AND METHODS
pAF and TMR aptamer in vitro selection
Pool design. Libraries of 1014 sequences were chemically
synthesized as DNA oligonucleotides (Keck Facility, New
Haven, CT, USA) (Supplementary Figure 1). The pAF
selection used a library containing a designed 12-base
stem-tetraloop (30) flanked on each side by 28 random
nucleotides (STR pool). The library pool for the TMR
aptamer selection was comprised of two equal portions.
The RAN2 portion of the pool had a straight run of 72
random nucleotides while the structured portion of pool
(STR2) contained a designed 12 base stem–tetraloop
flanked on each side by 30 nt of completely random
sequence. All sequences contained 50 40 nt T7 promoter/
PCR primer binding sites and 30 Reverse Transcription
and PCR (RT-PCR) primer binding sites (19).
Reselection pools were created from the sequences
isolated in the initial selections, with new RT and PCR
primers designed with Tm=55
C. The aptamer region
was doped with a mixture of 79% original base, and the
A B
Figure 1. Chemical structures of target ligands. (A) pAF;
MW=180 g/mol and (B) TMR; MW=343 g/mol.
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other bases at a coupling-efficiency balanced ratio of
7% each.
In vitro transcription. Pools were transcribed with T7
RNA polymerase, in transcription buffer containing
20mM each NTP, 25mM Mg2+, 40mM Tris (pH 7.8),
2.5mM spermidine, 10mM DTT, 0.01% Triton X-100,
50U T7 RNA Polymerase, 10U/ml thermostable inor-
ganic pyrophosphatase (TIPP, New England Biolabs,
UK), 200U/ml RNAsin (Promega) and, for the selection,
trace a32P-ATP (Perkin Elmer). The RNA was purified on
a PAGE gel, and ethanol (EtOH) precipitated with
potassium chloride (KCl).
Selection matrix preparation. 200 ml selection columns
were made by coupling the carboxy terminus of Fmoc-
p-aminophenylalanine-Boc (Bachem AG) to the amine-
terminus of NovaBiochem Amino PEGA resin (amino
polyethylene glycol) in dimethyl formamide (DMF).
Unreacted amine groups were blocked by acetylation
(31) and the Fmoc and Boc protecting groups were
removed using established procedures (32) to produce
0.5mM pAF columns. TMR matrix was similarly
prepared using 5-carboxy TMR (EMD Biosciences), but
without the deprotection steps.
In vitro selection. Selection columns were washed with
H2O, capped, inverted 2–3 times, and then pre-soaked in
4ml selection buffer (SB: 130mM K-glutamate (pH 7.5),
15mM NaCl, 10mM DTT and MgCl2 at various levels)
for 15–30min. This step was important because the
swelling characteristics of the PEGA resin differ between
the DMF solvent and water-based solvents. The RNA was
resuspended in 200 ml nuclease-free water and incubated at
37C for 5min. 2 SB and 4 ml each 200 mM acetylated
tRNAs and 100 BSA (10mg/ml) were added to the
RNA, and the mixture was agitated, applied to the
column and incubated for 5–30min.
Columns were then washed with 20 column volumes
(CVs) SB, 4 CV at a time. For the pAF selections,
elutions were performed in 2 CV fractions of 1mM pAF
in SB. After 6 CV, the columns were capped and 2 CV of
1mM pAF in SB was incubated for 30–60min, followed
by 4 CV of further wash. For the TMR selections, elutions
were performed in 2 CV fractions of 0.5mM TMR in SB.
As above, after 6 CV, the columns were capped and 2 CV
of 0.5mM TMR in SB was incubated for 30–60min,
followed by 4 CV of further wash. Fractions of
32P-labeled RNA were counted on a Beckman Coulter
LS 6500 liquid scintillation counter without scintillation
fluid. The column resin was also counted. All selections
were conducted at room temperature. The elution frac-
tions were pooled, and the RNA in these fractions was
de-salted using NAP-25 Sephadex columns (GE
Healthcare), EtOH precipitated with KCl and amplified
by RT-PCR using Ready-To-Go beads (GE Healthcare).
The resultant PCR product was either transcribed for the
next round of selection or cloned via TOPO cloning
(Invitrogen). At the end of the selection (see ‘Result
section’), 60–160 TOPO-cloned samples from each pool
were sequenced and aligned using ClustalW (33).
Binding constants and IC
Binding assays. Apparent Kds were determined with the
spin-filter method (10) using at least three independent
measurements taken across the linear range (40–60%
binding). Briefly, aptamer RNA was arranged in dilution
series in 100 ml volumes. For pAF binding assays, samples
were heated to 85C for 5min. 100 ml of 2 SB containing
0.5 nM 3H-labeled pAF (Moravek Biochemicals) and
either 1–10mM Mg2+ was added and samples
equilibrated at room temperature for at least 2 h (sufficient
to reach equilibrium, data not shown). Samples were
transferred to Microcon YM-10 spin columns
(Millipore), spun for 5 s at 10 000g to saturate the
membrane. Collection tubes were replaced, and samples
were again spun for 60 s. 15 ml samples were collected from
the top and bottom of the column, added to 4ml of
EcoScint fluid, and counted for 3H on a Beckman LS
6500 for 3min to determine the fraction of pAF that
was bound to the aptamer.
The TMR binding assays were performed in a similar
manner, with the following modifications. The RNA was
heated to 37C for 5min and the second spin was 2min.
The amount of TMR bound to the aptamer was deter-
mined by measuring the relative fluorescence of 25 ml
samples taken from the top and bottom of the Microcon
YM-10 spin columns. Fluorescence was measured using a
TECAN Safire with excitation wavelength of 550 nm and
emission wavelength of 590 nm.
Calculating ICs. The IC of each aptamer was computed
using the reselection sequence data and predicted second-
ary structures (19). The IC is given by the sum of the
amount of information needed to specify each position
in the recognition loops and Watson–Crick (W–C)
base-paired stems. Positions in recognition loops that
are invariant require two bits of information,
two-base varying positions require one bit, and
four-base varying positions require zero bits to specify
their identities. For positions in stems, each nucleotide
involved in a W–C base-pair is specified by 1 bit (i.e.
2 bits for each W–C pair). The observed frequency,
Fi, of each base was normalized and adjusted in order to
calculate the aptamer ICs in terms of random sequence
space (19).
Correlation coefficients and regression. Non-parametric
tests of association were applied because these are rela-
tively insensitive to data that deviates from a normal
distribution (19). Spearman’s rank correlation test was
carried out using the ‘pspearman’ package for R
(R Foundation for Statistical Computing, Vienna,
Austria). Confidence intervals of 95% were used for
all rankings; significance was determined under the null
hypothesis of no correlation with a one-tailed test. P-
values were calculated from the test statistic as described
(19). Non-parametric line-fits were performed using
Kendall’s robust line fit provided in the ‘mblm’ package
for R. Bootstrap confidence intervals were computed
for the non-parametric line fits using the bias-corrected
percentile method with 10 000 replicates (34).
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Estimating functional group binding energies. The poten-
tial binding energy contributions of ligand functional
groups were approximated using intrinsic binding
energies derived through multiple regression analysis by
Andrews et al. (35). The potential contribution of individ-
ual functional groups was obtained by multiplying the
empirical ‘Ex’ value for each type of functional group
at 298K (35) by the number of moieties present in the
ligand (see Supplementary Table 3). Functional group clas-
sifications were taken from The CAS Registry accessed
via SciFinder Scholar (American Chemical Society,
Columbus, OH, USA) (also see Supplementary Table S3).
RESULTS
In vitro selection of pAF aptamers with varying
magnesium concentrations
We wanted to test how much of a constraint the concen-
tration of magnesium is on selecting high-affinity aptamers
to small molecule ligands. We carried out parallel selec-
tions for pAF-binding RNA aptamers in four different
concentrations of magnesium: 1, 2.5, 5 and 10mM. 1
and 2.5mM magnesium concentrations were chosen
because these are consistent with the amount of free mag-
nesium that is present in vivo, whereas 5 and 10mM mag-
nesium are typical in vitro selection conditions (31,36–38).
An initial pool of RNA was prepared by transcribing 3
1014 unique DNA templates designed to contain an
internal stem–tetraloop flanked by stretches of completely
random sequence (‘Materials and Methods’ section and
Supplementary Figure S1). The pool of RNA was then
divided into four equal parts to provide the starting
material for each of the parallel selections.
Before Round 8, <5% of the RNA in any of the four
selections bound to a pAF column, survived 20 column
volumes of wash, and specifically eluted with 0.5mM pAF
in solution. After that point, the fraction of the RNA
pools that bound and specifically eluted rapidly increased
(Figure 2). By Round 10, 25% of the total RNA in the
2.5mM magnesium selection exhibited binding and
elution with 0.5mM pAF, while 14%, 9% and 2% of
the total RNA in the 1, 5 and 10mM magnesium selec-
tions bound the column and eluted with pAF, respectively.
The four pools were sequenced after Rounds 8 and 10.
In Round 10, the 1mM magnesium selection was
dominated by two different sequences, pAF-R1-1 and a
less abundant pAF-4Z1. The 2.5mM magnesium sample
was almost entirely pAF-4Z1. Both the 5 and 10mM
samples had significant pAF-4Z1 populations. The
10mMmagnesium sample still contained significant diver-
sity though many of those sequences probably do not bind
well to the pAF ligand, as indicated by the small fraction
of the total pool RNA (2%) that bound and eluted in
Round 10. Overall, in the four pools combined, copies
of pAF-4Z1 accounted for 56% of the available
sequences, while pAF-R1-1 represented another 15% of
the sequences. Two more sequences with multiple copies,
pAF-2B and -4B, made up 2% of the combined pools.
Together these four clones represented more than 70% of
the total sequences (Supplementary Figure S2).
The activities of the four most abundant RNAs isolated
in Round 10 were measured in column-binding assays.
Of the four clones, only pAF-R1-1 and -4Z1 exhibited
significant binding. Approximately 29% of the pAF-
R1-1 RNA and 19% of the pAF-4Z1 RNA bound to a
pAF column, survived 20 column volumes of wash, and
specifically eluted with pAF in solution. In contrast, <5%
of the pAF-2B or pAF-4B RNA bound and specifically
eluted (Supplementary Table S1). pAF-R1-1 and -4Z1
were chosen for further analysis (see below).
In vitro selection of TMR aptamers in 1mM Mg2+
We anticipated that TMR would be a better binding target
for RNA than pAF and that it should be possible to
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Figure 2. Course of pAF and TMR aptamer selections. (A) Fraction of
total RNA surviving 20 CV of wash, by round, for each of the five
selections performed. The concentration of magnesium in the selection
buffer is indicated by the number following the name of the target
ligand, in mM. The selection pools were sequenced after Rounds
8 and 10. Fraction of the Round 8 (B) and Round 10 (C) pAF selection
pool sequences comprised of clones pAF-4Z1 (red) and pAF-R1-1
(blue) as a function of magnesium concentration in the selection buffer.
Table 1. ICs and affinities (apparent Kds) of the pAF- and
TMR-binding aptamers in 5 and 1mM Mg2+
Aptamer Size IC Kd nM Kd nM
(nt) (bits) (5mM Mg2+) (1mM Mg2+)
pAF-4Z1d3 68 71.5±0.5 3600±400 5400±2600
pAF-R1-1 68 59.0±1.5 18 600±8400 103 000±5800
TMR1 38 47.5±1.0 85±25 70±15
TMR2 46 50.0±1.0 70±25 65±20
TMR3 54 65.0±2.5 370±150 400±230
TMR4 40 36.0±1.0 5000±1600 10 900±200
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recover high-affinity TMR aptamers in 1mM Mg2+ and
possibly from an unstructured sequence pool. Therefore a
single selection for TMR was conducted in 1mM Mg2+
with a starting pool of RNA transcribed from an equal
mixture of two populations totaling 3 1014 unique DNA
templates. One portion contained a designed internal
stem–tetraloop (STR2 library), as above, while the other
contained a completely random region (RAN2 library)
(‘Materials and Methods’ section).
After 10 rounds of selection, 25% of the RNA bound
to a column derivatized with 5-carboxy TMR, survived 20
column volumes of wash and specifically eluted with
0.5mM TMR in solution (Figure 2A). At this point, the
fraction of TMR aptamer pool RNA binding and eluting
from the selection column was equal to or greater than the
fractions of pAF aptamer pool RNAs that bound and
eluted from the pAF selection columns. Despite similar
column-binding profiles, sequencing showed that the
output of the TMR aptamer Round 10 selection
pool contained significantly more diversity than the
pAF aptamer selection pools had contained at the same
point. Specifically, 14 distinct clones comprised 70%
of the TMR aptamer selection pool compared to
only 4 distinct clones that comprised 70% of the
combined pAF aptamer selection pools (Supplementary
Figures S2 and S3). This is consistent with our expecta-
tion that there should be many more structural solu-
tions to the problem of binding the higher MW TMR
ligand than to the problem of binding the lower MW
pAF ligand.
Ten of the 14 unique TMR aptamer selection pool
sequences originated in the portion of the starting
library containing the designed stem–tetraloop, as did all
of the RNA sequences that showed substantial binding
(>5% binding and specifically eluting with 0.5mM
TMR) in column-binding assays (Supplementary
Figure S3 and Supplementary Table S2). Thus, the differ-
ence in the number of unique clones that bind TMR
compared to the number of unique clones that bind
pAF does not appear to be due to variations in the
starting sequence libraries. Four of the TMR aptamers
that exhibited substantial activity in the column-binding
assays (TMR1, TMR2, TMR3 and TMR4) were arbi-
trarily chosen for further study (Figure 3).
Reselections to optimize binding affinity and measure IC
We performed reselections of the pAF and TMR-binding
RNAs to identify functional sequence variants to optimize
binding to the target ligand and to determine the amount
of IC required to specify each of the structures.
Figure 3. Secondary structures of aptamers selected here. The size (in nucleotides), IC (in bits) and apparent Kd (in nanomolars) in 5mM Mg
2+ are
shown for each aptamer. Red circles indicate positions that are invariant, green circles indicate positions that vary between two bases and blue circles
indicate positions that can be any base. Watson-Crick (W-C) base-paired stems designed to flank the putative recognition bulges appear on the left in
each secondary structure. Positions referenced in the the text are numbered.
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Reselection pools were transcribed from chemically-
synthesized oligonucleotide pools mutated at a rate of
21% per position. After five rounds of selection in 1mM
Mg2+ buffer, >20% of the RNA in each of the
reselections bound to the column and specifically eluted
with the respective ligand in solution. At that point, the
reselection pools were cloned and sequenced.
Upon analyzing the reselection sequences, we found
that there were three variations in the pAF-4Z1 alignment
that occurred more often than predicted by chance
(Supplementary Figure S4). A8 changed to U in 25% of
the sequences (39 out of 153 sequenced clones), A16
changed to G in 22% of the sequences and C18 changed
to U in 58% of the sequences. The latter two mutations
appeared together in 11 out of 153 sequences and all three
mutations were observed together once. We measured the
apparent Kd of a sequence containing all three mutations
(aptamer pAF-4Z1d3) in a solution binding assay and
found a 20-fold reduction in Kd compared to the
original isolate (Table 1). One of the sequences recovered
from the pAF-R1-1 reselection had a deletion in the
designed internal stem–tetraloop. Replacing the 12 nt
after C31 that comprise the designed stem–tetraloop with
a short 3 nt sequence does not alter the binding affinity of
pAF-R1-1 compared to the original isolate (Table 1 and
Figure 4).
The region of TMR3 between C13 and G24 showed
covariation indicative of a W–C base-paired stem.
Replacing that portion of TMR3 with a designed stem–
tetraloop yielded a structure that binds with a
submicromolar Kd (Table 1). W–C base-paired stems,
appearing on the left of each secondary structure in
Table 2. Ligand structures and ICs of aptamers in literature
Ligand Structure MW (g/mol) IC (bits) Kd nM (5mM Mg
2+) No. of aptamers
Tyrosine (36) 181 75 23 000 1
Isoleucine (38,40) 131 33–38 600 000–1 200 000 2
Phenylalanine (31) 165 70 45 000 1
GMP (19) 363 32.5–67 9–8000 11
AMP (41) 363 35 1000 1
Theophylline (10) 180 37 320 1
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Figure 4, were designed to flank the putative recognition
loops in all of the aptamers. No other structural changes
were made to TMR aptamers 1, 2 or 4.
We calculated the IC of each aptamer structure as a
measure of the difficulty of binding the target ligands in
specified buffer conditions (19). IC was computed as a sum
of the information content needed to specify the loops of
each structure, obtained from the per-position frequencies
of each base identified in the reselections, and the infor-
mation content needed to specify the W–C base-paired
stems. The ICs for the pAF aptamers are substantially
greater than the ICs for all of the TMR aptamers except
TMR3 (Table 1). The fact that the pAF aptamers are
longer than all of the TMR aptamers and are more
informationally complex than three of the four TMR
aptamers provides objective evidence that TMR is a
better binding target for RNA than pAF.
Magnesium dependence
We examined the extent to which the aptamers depend
upon magnesium for activity by measuring the apparent
Kds as a function of Mg
2+. The pAF-4Z1d3, TMR1,
TMR2 and TMR3 aptamers exhibit the same Kds for
their target ligands in a physiological concentration of
magnesium (1mM) as they do in more permissive condi-
tions (5mM) (Table 1). In contrast, the TMR4 aptamer
Kd is 2-fold higher in 1mM Mg
2+ than in 5mM Mg2+.
The pAF-R1-1 aptamer shows an even greater dependence
on magnesium concentration: the pAF-R1-1 Kd is more
than 5-fold higher in 1mM Mg2+ than in 5mM Mg2+.
For illustrative purposes, the pAF aptamer Kds are plotted
as a function of Mg2+ concentration in Figure 4. The
sigmoidal curve fit of the pAF-R1-1 Kd versus Mg
2+ con-
centration data has a Hill coefficient of 3.4, suggesting that
there are specific metal binding sites that must be occupied
to form the active structure, as compared to a more
general need for counterions (39).
Figure 5 illustrates magnesium dependence as the differ-
ence in binding affinities in 1mM Mg2+ and 5mM Mg2+
[i.e. (G of binding in 1mM Mg2+) - (G of binding in
5mM Mg2+)=G of binding]. As aptamer affinity
in 5mM Mg2+ decreases (higher Kd), there is a larger
difference between 1 and 5mM Mg2+ binding affinities
(Spearman correlation coefficient, rs=0.94, P=0.008).
Put another way, aptamers that bind their ligands
more tightly (lower Kd) exhibit less dependence on mag-
nesium than aptamers with higher Kds, implying that the
same structural mechanisms that confer high-affinity
binding may also obviate the need for high levels of
magnesium.
DISCUSSION
In vitro selection produces the simplest (i.e. the least
informationally complex) structural solutions to a given
problem (19). It is timely to revisit the general question of
RNA aptamer IC and functional activity, first explored by
Carothers et al. and later by others (42–48), in light of new
interest in generating RNA aptamers to bind small
molecule targets in vivo. Beyond the need for the in vitro
selected aptamers to bind in physiological conditions,
the nature of the target ligand may place further restric-
tions on the ability to generate functional structures. In
practice, there may be limitations on the kinds of ligands
to which RNA aptamers can be in vitro selected to bind in
physiological conditions with affinities that are sufficient
for metabolic engineering and synthetic biology
applications.
Structural and biochemical analysis of aptamer-ligand
complexes has shown that steric complementarity, planar
stacking and intercalation and hydrogen bonding are the
Figure 4. Magnesium dependence of pAF aptamers. pAF-R1-1 shows
significant magnesium dependence, and fitting a parameterized curve to
the data gives a Hill coefficient of 3.4, results for pAF-R1-1d (stem-
tetraloop removed) are superimposed as asterisk symbols (*).
pAF-4Z1d3 maintains its Kd in a small band of 3–7 mM with no
discernible trend.
Figure 5. pAF and TMR aptamer magnesium dependence. The aptamer
free energy of binding in 1mMMg2+ minus the free energy of binding in
5mM Mg2+ (G of binding) is plotted against log10 aptamer Kd in
5mM Mg2+.
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primary modes of interaction (49,50). Because of this,
intrinsic chemical properties of the target molecule, such
as MW, the number of rotatable bonds and the number of
polar groups potentially serving as hydrogen bond donors
and acceptors are likely to be important for determining
the affinity of aptamers that can be isolated using in vitro
selection. As a consequence, it is reasonable to expect that
aptamers that bind small, flexible, hydrophobic molecules
may be less abundant in a pool of random sequences than
aptamers that bind with equal affinity to larger, more
planar, and more polar ligands (19).
Generalizing to other ligands
Through a literature search we collected in vitro selected
aptamers that bind six different small molecules whose ICs
were either previously presented or could be estimated
from published data (Table 2). These included four
aptamers that bind amino acids (one binds tyrosine, two
isoleucine and one phenylalanine), 11 aptamers that bind
guanosine mono/triphosphate (GMP), one aptamer that
binds adenosine mono/triphosphate (AMP) and one
aptamer that binds the xanthine alkaloid theophylline.
We plot the ICs and binding affinities of aptamers from
the literature alongside data for the two pAF and
four TMR aptamers selected and characterized here in
Figure 6. All of the aptamers from the literature were
selected in 5mM Mg2+. For consistency, all of the Kds
in Figure 6 are for binding in 5mM Mg2+.
Interestingly, the amino acid-binding aptamers selected
elsewhere and the pAF aptamers selected here fall into a
region of the IC versus Kd plot that is distinct from the
region of the plot where the aptamers that bind the larger
ligands TMR, GMP and AMP appear. Without
exception, aptamers that bind the amino acids (ligand
MWs=131–181 g/mol) are more informationally complex
and/or have lower affinities for their ligands than the
aptamers that bind TMR, GMP and AMP (ligand
MWs=343–363 g/mol). Thus, to a first approximation,
the IC versus affinity relationship appears to be dictated
by ligand MW, a finding that may be consistent with the
weak correlations between affinity and ligand mass
observed in other studies (50).
The red and grey lines in Figure 6 are line fits of the data
for the set of amino acid-binding aptamers and the
extensively characterized GMP aptamers (19), respec-
tively. For the set of amino acid binding aptamers, the
informational cost of each 10-fold increase in binding
affinity is 15±8 bits. This value agrees with the
informational cost of a 10-fold improvement in GMP
aptamer binding affinity (10±5 bits, equal to a 1000-
fold decrease in abundance in a pool of random
sequences) and the informational cost of a 10-fold
improvement in binding affinity for the entire set of
aptamers that bind the larger ligands (8±2 bits).
Therefore, we take the horizontal distance between the
lines at a given IC to represent the average difference
in potential binding affinity that can be ascribed to the
difference in ligand MWs. Specifically, the average
affinities of aptamers that bind the smaller MW ligands
(MW=131–181 g/mol) are 1000-fold worse than the
the average affinities of aptamers that bind the larger
MW ligands (MW=343–363 g/mol). Equivalently, 40
bits of additional IC are needed, on average, to specify
an aptamer that binds an amino acid-sized ligand
with the same affinity as an aptamer that binds a larger
ligand.
The Jenison (10) theophylline aptamer is a significant
outlier on this plot since it has an affinity for the target
that is several orders of magnitude higher than predicted
based solely on MW (open triangle pointed up in
Figure 6). It has an IC versus affinity relationship that
resembles the aptamers that bind the larger ligands, even
though the theophylline MW is only 180 g/mol. We can
begin to understand this apparent discrepancy by consid-
ering other characteristics of the target ligands.
Table 3 shows estimates for the potential free energy of
binding (35) intrinsic to the theophylline ligand functional
groups compared to the average potential free energy
of binding for the functional groups in the amino acids
and larger ligands (also see Supplementary Table S3).
Employing values for the intrinsic binding potential of
each type of functional group calculated by Andrews
et al. (35), we find that the potential energy contributions
of the carbons and polar groups in theophylline are similar
to the average potential energy contributions of the
carbons and polar groups in the amino acids.
In contrast, we note that theophylline has fewer rotat-
able bonds than the ligands in either set (Supplementary
Table S3). Fixing a rotatable bond in a ligand, which
reduces the internal degrees of freedom (DOF), has been
determined to contribute as much as 0.6–1.0 kcal/mol to
the free energy of binding (35,51). Based on the Andrews
et al. functional group intrinsic binding energies, the fixed
bonds in theophylline could contribute, on average,
Figure 6. Aptamer IC versus binding affinity. Aptamer IC in bits is
plotted against log10 apparent Kd in 5mM Mg
2+. Line fit of the GMP
aptamers (19) is grey; line fit of the amino acid-binding aptamers is dark
red. The Spearman rank correlation coefficient (rs) for informational com-
plexity and binding affinity for the GMP aptamers is 0.65, P< 0.025,
rs=0.67, P< 0.0025 for the GMP, AMP and TMR aptamers and
rs=0.83, P< 0.030 for the amino acid aptamers. The orange dotted
line connects positions on the graph between the actual theophylline
aptamer IC versus Kd relationship (triangle pointed up) and the
theophylline aptamer IC versus Kd relationship adjusted for the number
of rotatable bonds relative to the set of amino acids (triangle pointed
down).
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3.2 kcal/mol of favorable binding energy to the affinity of
the theophylline aptamer relative to the amino acids
(Table 3). Interestingly, subtracting 3.2 kcal/mol from
the binding affinity of the theophylline aptamer moves
that data point toward a region of the graph consistent
with the IC versus Kd relationship predicted on the basis
of MW alone (orange triangle pointed down in Figure 6).
Caution should be exercised when using this approach
to make predictions because of our limited dataset and
the uncertainty in ascribing values for the intrinsic
binding energy of individual ligand functional groups in
RNA-ligand interactions (35,51). With these important
caveats, we suggest that this treatment may be employed
as a rough guide for estimating potential binding affinities
relative to other aptamer–ligand Kds. Extending this
analysis to aptamers that bind other ligands differing in
MWs and with a variety of functional groups should
enable aptamer binding affinity predictions to be further
refined.
Estimating the maximal Kd
Ultimately, we would like to develop a mathematical
framework for predicting the potential IC/Kd ratio
because this is useful for determining what affinities are
accessible with a particular sequence pool length, diversity
and design. We have shown that aptamer IC versus Kd
relationships can be used to begin understanding how
ligand MW and the number of rotatable bonds affect
potential binding affinities. For aptamers with an
internal stem–tetraloop and ICs <55 bits, the prior prob-
ability of occurring in a pool with a sequence design and
diversity (1014 unique sequences) similar to STR and
STR2 is approximately one (19). This implies that it
should always be possible to isolate aptamers from these
pools to bind a ligand with a given affinity if <55 bits of
IC are needed to specify those structures.
In contrast, the prior probabilities for the most
informationally complex aptamers are much less than
one and are, therefore, expected to be among the highest
affinity structures that can be selected from libraries with
the lengths, diversities and designs of STR and STR2. For
example, the prior probability that pAF-4Z1d3, whose Kd
for pAF is 3.6 mM, will be present in the STR/STR2
pool is <0.0001 (Supplementary Table S4). The prior
probabilities of the most complex and highest affinity
GMP aptamers (Kds for GMP=10–30 nM) in structured
pools were previously shown to be <0.0035 (19).
We suggest that the lowest Kds attainable for aptamers
selected from pools like these to bind ligands similar to the
amino acids are in the low micromolar range and that the
lowest Kds attainable for aptamers that bind molecules
similar to the larger targets (i.e. planar moieties with
MW 350 g/mol) are in the low nanomolar range. It
may be possible to generate high-affinity aptamers that
bind targets smaller than pAF and TMR or molecules
with more internal DOF, but this will likely require
structurally-complex sequence libraries with additional
designed elements (47) that ‘pre-pay’ more of the IC (19).
Implications of magnesium and IC relationship
Two lines of evidence suggest that there is a general rela-
tionship between IC, Kd, and magnesium sensitivity
(illustrated by G of binding between 1 and 5mM
Mg2+) in aptamer structures. First, we observe that the
Kds of the highest affinity aptamers are not sensitive to
the concentration of Mg2+ (Figure 5). For instance, the
Kds of the higher affinity pAF aptamer and the three
highest affinity TMR aptamers are the same in 1 and
5mM Mg2+. In contrast, the aptamer with the highest
Kd in both sets exhibits sensitivity to the concentration
of Mg2+ (Figure 4).
We also note that the pAF-4Z1 and pAF-R1-1 aptamers
dominated the selection pools in all of the Mg2+ condi-
tions (Figure 2). Despite retaining significant sequence
diversity in the last rounds, even the most permissive selec-
tion (in 10mMMg2+) had a pool where nearly 30% of the
clones were pAF-4Z1. If there were other high-affinity
aptamers in the library pool that can only bind in permis-
sive magnesium conditions, then they should have
been recovered from the 5 and 10mM Mg2+ selections.
The fact that this did not happen provides further evidence
that selection in stringent magnesium conditions
simultaneously selected for tighter-binding aptamers.
Khvorova et al. (52) were amongst the first to observe
that the concentrations of Mg2+ required for high rates of
hammerhead ribozyme self-cleavage are greatly reduced
by structural elements (interaction loops) outside the
minimally-active core that stabilize the tertiary fold (53).
Penedo et al. (54) elucidated the magnesium sensitivity of
minimal hammerhead ribozymes along with those harbor-
ing the interaction loops: the presence of two 3–8 bp loop
structures rescues functionality in low (1mM) magnesium
relative to structures that do not contain the loop struc-
tures. Notably, the structural stability engendered by the
interaction loops not only reduces the need for magnesium,
but also increases the overall cleavage rates. Interaction
loops increase the cleavage rate (kobs) of minimal hammer-
head ribozymes 35–70 fold in 0.1mM Mg2+ (52) and
4-fold in 10mM Mg2+ (55). Interestingly, the minimal
hammerhead ribozyme and the pAF-R1-1 aptamer have
similar degrees of magnesium sensitivity, as indicated by
Table 3. Intrinsic ligand functional group binding energies
Ligand set MW Carbons Polar DOF
(sp2, sp3) (N+, N,
OH, O, S)
(g/mol) (kcal/mol) (kcal/mol) (kcal/mol)
pAF, Tyr, Ile, Phe 164 5.4 12.4 3.2
TMR, GMP, AMP 366 10.3 13.8 3.7
Theophylline 180 5.1 11.6 0
Intrinsic ligand binding energies were calculated using the functional
group binding energies (‘Ex’) presented by Andrews et al. (35). The
mean intrinsic binding energies (in kcal/mol) for the functional
groups within each set of ligands is given. Carbons (Csp2, Csp3) cor-
responds to the potential binding energy attributable to planar and
aliphatic carbons. The potential binding energy penalty ascribed to
rotatable bonds is listed under the DOF heading. Supplementary
Table S3 enumerates the functional groups for individual ligands and
the Ex values employed for these calculations.
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the fact that the half-maximum activity point is 2mM
Mg2+ for both structures [Figure 4 (54)].
We can approximate the IC needed to specify the ham-
merhead ribozyme interaction loops based on the pub-
lished secondary and tertiary structures (52,53). There
are about 11 bases within the loops themselves that are
two-base varying (0.5 bits/nt=5.5 bits) and two longer
stems (2–3 bp each=8–12 bits), totaling 13.5–17.5 bits of
additional IC compared to the minimal hammerhead
ribozyme. To put this value into perspective, 10 more
bits of IC are needed to increase aptamer binding
affinity by a factor of 10 and 40 more bits are required
to specify an aptamer with the same affinity for an amino
acid as one of the larger ligands (see above).
Taken together, we find that for a set of aptamers to a
particular ligand, additional information (which in turn
defines structure) produces more robust structures; i.e.
structures that function in physiological magnesium con-
centrations. In the case of aptamers, this additional IC
appears to result in not only greater affinity but also less
reliance on magnesium for functionality. Perhaps addi-
tional structural elements within the aptamers improve
the stability of the active conformations, resulting in
higher binding affinity and less need for magnesium in
the same way that the interaction loops stabilize the ham-
merhead ribozyme structure, increasing kobs and allowing
for cleavage in physiological magnesium conditions. These
findings are notable in light of the observation that
high concentrations of magnesium are often necessary
for high levels of RNA functionality (5,52,54–58). The
evidence discussed here suggests that dependence on
magnesium for functionality can be readily overcome by
additional structure (information). Although additional
study is clearly warranted, we hypothesize that the goals
of high-affinity binding and in vivo functionality are
attainable in concert rather than in competition.
Integrating aptamers into control devices
There are several immediate applications in synthetic
biology and metabolic engineering for aptamer-based
control devices: for sensing specific molecules in the envi-
ronment; as in situ readouts for detecting product forma-
tion, useful for screening or evolving high-yield enzymes
and pathways; and for creating small molecule-responsive
feedback or feedforward controls in engineered systems
(9). For example, an engineered metabolic pathway may
have toxic intermediates whose concentrations could be
dynamically regulated by controlling the expression of
enzymes that produce them.
Knowledge about the concentration at which an inter-
mediate is toxic could be used to estimate the IC needed
to select an aptamer that binds in that regime (Figure 6).
In some cases, this analysis may indicate that aptamers
cannot be selected to bind a potential target with sufficient
affinity. In others, there may be several metabolic interme-
diates that could serve as signals for aptamer-based
pathway regulation. Choosing the largest intermediates
with the fewest number of rotatable bonds should
improve the chances of a successful aptamer selection.
By recognizing which molecular characteristics contribute
positively to potential RNA binding, one can, at the least,
estimate the affinity range (mM, mM, nM) obtainable for a
given ligand and design sequence libraries and selection
protocols accordingly.
Once isolated, aptamers should be reselected as above,
in order to improve Kds, and to obtain structural data.
These data, such as which areas are stems, which bases
can vary (blue and green bases in Figure 3) and which are
unnecessary (such as the structured stem-tetraloop in
pAF-R1-1 that was removed), can aid the integration of
the aptamer into a biologically active context. For
example, by combining pAF-R1-1 with a hammerhead
ribozyme we have evolved pAF-responsive aptazymes
that function in vitro and control gene expression in
E. coli (Goler et al., manuscript in preparation).
CONCLUSION
The ability to rapidly select aptamers to target small mol-
ecules enables their use for in vivo sensing and control in
engineered biological systems. The evidence presented
here suggests that selection for high-affinity binding
produces aptamers that do not require high concentra-
tions of magnesium for activity. This may mean that selec-
tion for high-affinity aptamers to function in in vivo is not
significantly constrained by the need to bind in physiolog-
ical levels of magnesium.
We have shown that it may be possible to estimate the
IC required to specify a structure that binds a ligand with
a particular affinity before a selection is performed. To a
first approximation, the potential aptamer binding affinity
for a target can be predicted on the basis of the MW of the
ligand. Predictions of achievable aptamer–ligand affinities
are further improved by considering ligand properties
such as the numbers of rotatable bonds and potential
hydrogen bond donors and acceptors. Because IC is
directly related to the probability that a structure will be
present in a combinatorial sequence pool, we hypothesize
that this analysis can be used to design libraries and
selections that are more likely to yield aptamers of the
desired affinity. Aggregating more comprehensive data
on aptamers – their targets, affinities and ICs – will test
this hypothesis and feasibly enable more accurate predic-
tions of obtainable aptamer–ligand affinities.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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